Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration
批准号:
10376248
负责人:
Daniel Raphael Saban
金额:
$43.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2024-03-31
关键词:
AddressAgeAnaphylatoxinsBlindnessBone MarrowBone Marrow PurgingC3AR1 geneCell DeathCellsChemotaxisChimera organismClinicalComplexCytoprotectionDataData SetDefectDevelopmentDiseaseEnvironmentEtiologyExcisionExplosionEyeGalectin 3GeneticGenetic TranscriptionImmuneImmune responseIn SituInterruptionKnock-in MouseKnock-outKnockout MiceKnowledgeLeadLeftLettersLifeLigandsLightMediatingMethodsMicrogliaModelingMolecularMolecular ProfilingMusMyeloid CellsNeuraxisNeuronsOutcomePathologyPatientsPhagocytesPhagocytosisPharmacologyPhenocopyPhotoreceptorsPhysiologicalPhysiologyPlayPopulationProcessPropertyProtein Tyrosine KinaseReagentReporterRetinaRetinal DegenerationRetinal DiseasesRhodopsinRoleSeriesSignal TransductionStargardt&aposs diseaseStructure of retinal pigment epitheliumTREM2 geneTechniquesTestingTimeTissuesTransgenic OrganismsValidationVisionexperimental studygain of functionimaging modalityin vivoloss of functionmacrophagemigrationmolecular dynamicsmonocytenew therapeutic targetnovelnovel therapeutic interventionnovel therapeuticspatient populationphotoreceptor degenerationprenatalpreservationprogramsreceptorrecruitresponsesingle-cell RNA sequencingsmall moleculetool
中文摘要
摘要
许多(如果不是大多数)视网膜变性涉及视网膜下巨噬细胞的异位聚集。
然而,真正的小胶质细胞对这种免疫反应的贡献及其在疾病中的独立作用
人们对此知之甚少。现在人们普遍认识到,退化神经元组织中的巨噬细胞不是
仅由小胶质细胞组成,但也可能包括单核细胞来源的巨噬细胞。前者是内生性的
出生前衍生的细胞在整个生命过程中保持在局部,而后者代表瞬时招募
处于疾病状态的乘客。因此,这两个不同的谱系在疾病中具有非多余的活动。
因此,应将其作为不同的实体加以研究。然而,从技术上讲,区分小胶质细胞
具有挑战性的标准技术,如免疫标记、常规报告小鼠或骨髓清除术
骨髓嵌合体不足以研究这两个群体。事实上,实现这一目标的唯一方法
分离是通过最近建立的CX3CR1-Creer小胶质细胞谱系追踪小鼠进行的。然而,很少有研究表明
采用了这一方法,这导致了该领域的知识差距。正如现在所知,
小胶质细胞在生理条件下建立和保存神经元活动是必不可少的,决定
视网膜疾病中的小胶质细胞特异性活动现在势在必行。使用血统追踪方法和单一的-
细胞RNA测序(scRNA-seq),我们的实验室最近发现了一个新的细胞保护性视网膜种群
光感受器变性模型中的小胶质细胞。我们现在希望在我们目前的研究成果的基础上
通过应用新的工具来机械地解开这些细胞并确定其意义
他们的细胞保护计划跨越不同的病因视网膜退行性疾病。我们从目标1开始
利用我们的scRNA-seq数据集来抑制小胶质细胞的趋化作用,这将使我们能够确定
细胞保护是一种视网膜下特异性反应。Aim 2也利用了我们的scRNA-seq数据集
有针对性的条件性和全局性基因敲除建立小胶质细胞介导的分子基础
保护。最后,在目标3中,我们将应用功能损失和功能增益研究来检验这一点
细胞保护性小胶质细胞程序对初级光感受器变性和视网膜色素均有效
上皮病理相关变性。总而言之,我们的建议不仅是及时的,而且也准备好
解开这种新的小胶质细胞群在病因上不同的视网膜变性中的内部结构
模型,也许有助于发现新的治疗靶点,可以增强他们的视力活动
光感受器退行性变的保存。
英文摘要
SUMMARY
Many, if not most, forms of retinal degeneration involve ectopic accumulation of subretinal macrophages.
However, the contribution of bona fide microglia to this immune response and their independent role in disease
is poorly understood. It is now widely appreciated that macrophages in degenerating neuronal tissues are not
only comprised of microglia but may also include monocyte-derived macrophages. The former are endogenous
prenatal-derived cells maintained locally throughout life, whereas the latter represent transiently recruited
passengers in disease states. Hence, these two distinct lineages have nonredundant activities in the disease
process and should thereby be studied as distinct entities. However, distinguishing microglia is technically
challenging since standard techniques such as immunolabeling, conventional reporter mice, or myeloablation
bone marrow chimeras are insufficient to study these two populations. In fact, the only method to achieve such
separation is through recently established Cx3cr1-CreER microglia lineage tracing mice. Yet, few studies have
employed this approach, which has resulted in a knowledge gap in the field. As it is also now known that
microglia are essential in establishing and preserving neuronal activity in physiological conditions, determining
microglia-specific activities in retinal disease is now imperative. Using the lineage tracing approach and single-
cell RNA sequencing (scRNA-seq), our lab recently identified a novel population of cytoprotective retinal
microglia in photoreceptor degeneration models. We now wish to build upon these findings in our current
proposal by applying novel tools to unravel these cells mechanistically, as well as to determine the significance
of their cytoprotective program across etiologically distinct retinal degenerative diseases. We begin in Aim 1 by
leveraging our scRNA-seq dataset to inhibit microglial chemotaxis that will allow us to determine whether
cytoprotection is a subretinal-specific response. Aim 2 takes advantage of our scRNA-seq dataset as well for
targeted conditional and global knockouts to establish the molecular underpinnings of microglia-mediated
protection. Lastly, in Aim 3 we will apply loss- and gain-of-function studies to examine whether this
cytoprotective microglial program is operative in both primary photoreceptor degeneration and retinal pigment
epithelial pathology-related degeneration. In summary, our proposal is not only timely, but is also poised to
unravel the innerworkings of this novel microglial population across etiologically distinct retinal degeneration
models and perhaps help uncover novel therapeutic targets that can bolster their activities for vision
preservation in photoreceptor degeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration
-
批准号:10223314
-
项目类别:
-
资助金额:$44.31万
-
财政年份:2020
-
负责人:Daniel Raphael Saban
-
依托单位:
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration
-
批准号:10601032
-
项目类别:
-
资助金额:$44.07万
-
财政年份:2020
-
负责人:Daniel Raphael Saban
-
依托单位:
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy
-
批准号:9037256
-
项目类别:
-
资助金额:$8.01万
-
财政年份:2015
-
负责人:Daniel Raphael Saban
-
依托单位:
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy
-
批准号:8462836
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2012
-
负责人:Daniel Raphael Saban
-
依托单位:
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy
-
批准号:8604394
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2012
-
负责人:Daniel Raphael Saban
-
依托单位:
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Disease during Severe Allergic Inflammation
-
批准号:9919560
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2012
-
负责人:Daniel Raphael Saban
-
依托单位:
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy
-
批准号:8410582
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2012
-
负责人:Daniel Raphael Saban
-
依托单位:
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy
-
批准号:8246069
-
项目类别:
-
资助金额:$9.7万
-
财政年份:2012
-
负责人:Daniel Raphael Saban
-
依托单位:
Defining the Immune Cell Roles in Meibomian Gland Dysfunction in the Context of Ocular Surface Immune Diseases
-
批准号:10707387
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2012
-
负责人:Daniel Raphael Saban
-
依托单位:
Cellular and Molecular Mechanisms that Contribute to Ocular Surface Allergy
-
批准号:8997093
-
项目类别:
-
资助金额:$45.15万
-
财政年份:2012
-
负责人:Daniel Raphael Saban
-
依托单位:
Composite Allografting for Promoting Survival of Corneal Transplants
-
批准号:7878675
-
项目类别:
-
资助金额:$5.38万
-
财政年份:2009
-
负责人:Daniel Raphael Saban
-
依托单位:
Composite Allografting for Promoting Survival of Corneal Transplants
-
批准号:7677758
-
项目类别:
-
资助金额:$5.17万
-
财政年份:2009
-
负责人:Daniel Raphael Saban
-
依托单位:
Flow Cytometry Module
-
批准号:10273186
-
项目类别:
-
资助金额:$12.86万
-
财政年份:1997
-
负责人:Daniel Raphael Saban
-
依托单位:
Flow Cytometry Core
-
批准号:10006549
-
项目类别:
-
资助金额:$8.37万
-
财政年份:1997
-
负责人:Daniel Raphael Saban
-
依托单位:
Flow Cytometry Module
-
批准号:10472753
-
项目类别:
-
资助金额:$12.86万
-
财政年份:1997
-
负责人:Daniel Raphael Saban
-
依托单位:
Flow Cytometry Core
-
批准号:9152932
-
项目类别:
-
资助金额:$8.45万
-
财政年份:--
-
负责人:Daniel Raphael Saban
-
依托单位:
Flow Cytometry Core
-
批准号:9547853
-
项目类别:
-
资助金额:$8.37万
-
财政年份:--
-
负责人:Daniel Raphael Saban
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: